Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Christofidou-Solomidou (Philadelphia, United States of America). Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma. 1581

Member's Comments

No comment yet.

Related content which might interest you: Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma? Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015 Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016 Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 Non-malignant pleural disease from asbestos and malignant pleural mesothelioma Source: Eur Respir Monogr 2020; 89: 141-149 Year: 2020 Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019 Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007